VTRS
Viatris Inc
$16.04
0.06 (0.37%) Today
— up— down
Market Cap
$20.71B+54.1%
Revenue (TTM)
$14.75B+4.4%
Net Income (TTM)
$-415,860,805
$-415,860,805EPS (TTM)
-0.36
-0.36Shares Out
1.16B
1.16BForward P/E
6.97
6.97Dividend
$0.48 (2.70%)
$0.48 (2.70%)Ex-Dividend Date
May 22, 2026
May 22, 2026Open
$16.28
$16.28Previous Close
$16.10
$16.10Day Range
$15.99 – $16.38
$15.99 – $16.3852-Week Range
$9.43 – $18.39
$9.43 – $18.39Beta
0.87
0.87Earnings Date
Nov 4, 2026
Nov 4, 2026Volume
11.15M
11.15MAvg Volume
10.78M
10.78MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout VTRS
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.
Related
News
N/AN/AN/AN/AN/A
Viatris (VTRS) Q2 2026 Earnings Call Transcript
Yahoo · 2h ago
VTRS Q2 Deep Dive: China Growth, Pipeline Progress, and Margin Concerns Shape Outlook
Yahoo · 2d ago
Viatris (VTRS) Is Down 6.4% After Raising 2026 Guidance And Completing Major Buyback Program
Yahoo · 3d ago
Viatris (VTRS) Stock May Be Below Fair Value Despite FDA Patch Approval
Yahoo · 4d ago
Viatris (VTRS) Raises 2026 Guidance, Is The 11% Gap Below Fair Value Enough?
Yahoo · 4d ago